Kilter Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.8K Buy
72
+9
+14% +$3.34K 0.01% 216
2026
Q1
$18.4K Sell
63
-1
-2% -$329 0.01% 247
2025
Q4
$22.4K Buy
64
+12
+23% +$4.05K 0.01% 196
2025
Q3
$16.8K Buy
52
+31
+148% +$9.64K 0.01% 215
2025
Q2
$8.17K Buy
+21
New +$8.45K ﹤0.01% 300

Other funds holding ELV

Kilter Group's ELV Position: Q2 2026 in Review

Kilter Group increased its Elevance Health (ELV) stake by 14% in Q2 2026, buying an estimated $3.34K and bringing the position to 72 shares worth $27.8K. The position accounts for 0.01% of the portfolio, ranked #216.

Kilter Group first reported a position in ELV in Q2 2025 and has held it in 5 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Kilter Group held 72 shares of Elevance Health worth $27.8K as of Q2 2026.
  • Kilter Group bought 9 Elevance Health shares in Q2 2026, an estimated $3.34K.
  • Elevance Health made up 0.01% of Kilter Group's portfolio in Q2 2026, its #216 holding.
  • Kilter Group first reported a position in Elevance Health in Q2 2025 and has held it in 5 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.